The Community Guide

- gsearch

Search Results

Narrow Results:

2021 1

Journal Article 1

1 Results

Refine Results

Refine Results:

Long-acting buprenorphine vs. naltrexone opioid treatments in CJS-involved adults (EXIT-CJS)

CITE Title : Long-acting buprenorphine vs. naltrexone opioid treatments in CJS-involved adults (EXIT-CJS) Personal Author(s) : Waddell, Elizabeth Needham;Springer, Sandra A.;Marsch, Lisa A.;Farabee, David;Schwartz, Robert P.;Nyaku, Amesika;Reeves, Rusty;Goldfeld, Keith;McDonald, Ryan D.;Malone, Mia;Cheng, Anna;Saunders, Elizabeth C.;Monica, Laura;Gryczynski, Jan;Bell, Kathleen;Harding, Kasey;Violette, Sandra;Groblewski, Thomas;Martin, Wendy;Talon, Kasey;Beckwith, Nicole;Suchocki, Andrew;Torralva, Randy;Wisdom, Jennifer P.;Lee, Joshua D.; Published Date : 9 2021;9-2021; Source : J Subst Abuse Treat. 128:108389 URL : https://stacks.cdc.gov/view/cdc/111317 Waddell, Elizabeth Needham et al. (2021). Long-acting buprenorphine vs. naltrexone opioid treatments in CJS-involved adults (EXIT-CJS). 128 Waddell, Elizabeth Needham et al. "Long-acting buprenorphine vs. naltrexone opioid treatments in CJS-involved adults (EXIT-CJS)" 128 (2021) Waddell, Elizabeth Needham et al. "Long-acting buprenorphine vs. naltrexone opioid treatments in CJS-involved adults (EXIT-CJS)" vol. 128, 2021 Export RIS Citation Information.

:

Waddell, Elizabeth Needham ;

Springer, Sandra A.

9 2021 | J Subst Abuse Treat. 128:108389

:

The EXIT-CJS (N = 1005) multisite open-label randomized controlled trial will compare retention and effectiveness of extended-release buprenorphine ...

To see more results, try removing search filters or changing the search terms